Today: 16 June 2026
Browse Category

NASDAQ:TNYA 8 November 2025

Tenaya Therapeutics (TNYA) on Nov. 8, 2025: FDA Places Clinical Hold on TN‑201 Trial as AHA 2025 Showcases Encouraging MyPEAK‑1 Data

Tenaya Therapeutics (TNYA) on Nov. 8, 2025: FDA Places Clinical Hold on TN‑201 Trial as AHA 2025 Showcases Encouraging MyPEAK‑1 Data

The FDA placed a clinical hold on Tenaya’s MyPEAK-1 trial for TN-201, requiring protocol changes for patient monitoring and immunosuppression. Tenaya reported new interim data showing six treated patients had increased MyBP-C protein and improved cardiac biomarkers, with all six no longer symptomatic. Shares dropped over 20% after the hold was announced. The company does not expect data timelines to change.
8 November 2025
·

Stock Market Today

  • Graham Corporation (GHM) Jumps 3.5% on Defense Market Optimism
    June 16, 2026, 10:06 AM EDT. Shares of Graham Corporation (GHM) rose 3.5% to $107.57, driven by strong trading volume and optimism around defense sector momentum. The company benefits from robust demand in naval defense and growth in space programs. Despite expected quarterly earnings per share (EPS) of $0.36, down 20% year-over-year, revenues are projected to increase 20.2% to $66.68 million. However, analysts have cut Graham's EPS estimates by over 20% in the past month, indicating some caution. The stock holds a Zacks Rank #3 (Hold). Industry peer Parker-Hannifin (PH) also saw gains, closing 1.7% higher. Investors should watch for updates as earnings estimates trends often influence near-term stock moves.

Latest articles

Qualcomm Shares Rise on Tenstorrent Deal Talks and AI Push

Qualcomm Shares Rise on Tenstorrent Deal Talks and AI Push

16 June 2026
Qualcomm shares jumped 4.3% to $220.81 after reports it’s in talks to buy AI chip startup Tenstorrent for $8–$10 billion, as investors weigh the potential to diversify beyond smartphones ahead of the June 24 Investor Day, with the stock reflecting both excitement and uncertainty over the possible deal and the company’s AI strategy.
Rigetti Computing Stock Jumps as Quantum Rally Revives RGTI Risk Appetite

Rigetti Computing Stock Jumps as Quantum Rally Revives RGTI Risk Appetite

16 June 2026
Rigetti Computing surged 8.2% to $22.70 on heavy volume as quantum stocks rallied after D-Wave’s price target hike and HPE’s hybrid quantum announcement, but with just $4.4 million Q1 revenue against a $7.6 billion market cap, future growth is already priced in and the next earnings update is the key catalyst for investors.
CervoMed Shares Rise in Early Trade After $3 Million Insider-Related Purchase

CervoMed Shares Rise in Early Trade After $3 Million Insider-Related Purchase

16 June 2026
CervoMed soared over 30% premarket after an SEC filing revealed a trust linked to board chair Joshua S. Boger bought $3 million in units above Monday’s close, signaling insider confidence following last week’s $10.5 million private placement that extends cash runway but raises dilution risks; the next key catalyst is securing a strategic partner for neflamapimod’s Phase 3 dementia with Lewy bodies program.
Go toTop